Table of Contents Author Guidelines Submit a Manuscript
Journal of Ophthalmology
Volume 2017 (2017), Article ID 5601786, 5 pages
https://doi.org/10.1155/2017/5601786
Clinical Study

Real-Life Management of Patients with Retinal Vein Occlusion Using I-Macula Web Platform

1Clinica Oculistica-DINOGMI, Università di Genova and Italy Ospedale Policlinico San Martino, Genoa, Italy
2Fondazione per la Macula Onlus-Genova, Genoa, Italy
3Healthropy SRL, Genoa, Italy
4DIBRIS, University of Genoa, Genoa, Italy

Correspondence should be addressed to Massimo Nicolò; moc.liamg@olocinomissam

Received 26 April 2017; Accepted 28 June 2017; Published 24 July 2017

Academic Editor: Flavio Mantelli

Copyright © 2017 Massimo Nicolò et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. J. Rehak and M. Rehak, “Branch retinal vein occlusion: pathogenesis, visual prognosis, and treatment modalities,” Current Eye Research, vol. 33, no. 2, pp. 111–131, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. D. A. Antonetti, A. J. Barber, S. Khin, E. Lieth, J. M. Tarbell, and T. W. Gardner, “Vascular permeability in experimental diabetes is associated with reduced endothelial occludin content: vascular endothelial growth factor decreases occludin in retinal endothelial cells,” Diabetes, vol. 47, no. 12, pp. 1953–1959, 1998. View at Publisher · View at Google Scholar
  3. P. A. Campochiaro, G. Hafiz, S. M. Shah et al., “Ranibizumab for macular edema due to retinal vein occlusions: implication of VEGF as a critical stimulator,” Molecular Therapy, vol. 16, no. 4, pp. 791–799, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. M. L. Shahsuvaryan and A. K. Melkonyan, “Central retinal vein occlusion risk profile: a case-control study,” European Journal of Ophthalmology, vol. 13, no. 5, pp. 445–452, 2003. View at Google Scholar
  5. D. M. Brown, P. A. Campochiaro, R. P. Singh et al., “Ranibizumab for macular edema following central retinal vein occlusion: six-month primary end point results of a phase III study,” Ophthalmology, vol. 117, no. 6, pp. 1124–1133, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. J. A. Haller, F. Bandello, R. Belfort Jr et al., “Randomized, sham-controlled trial of dexamethasone intravitreal implant in patients with macular edema due to retinal vein occlusion,” Ophthalmology, vol. 117, no. 6, pp. 1134–1146, 2010. View at Publisher · View at Google Scholar · View at Scopus
  7. J. A. Haller, F. Bandello, R. Belfort Jr et al., “Dexamethasone intravitreal implant in patients with macular edema related to branch or central retinal vein occlusion: twelve-month study results,” Ophthalmology, vol. 118, no. 12, pp. 2453–2460, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. D. M. Brown, P. A. Campochiaro, R. B. Bhisitkul et al., “Sustained benefits from ranibizumab for macular edema following branch retinal vein occlusion: 12-month outcomes of a phase III study,” Ophthalmology, vol. 118, no. 8, pp. 1594–1602, 2011. View at Publisher · View at Google Scholar · View at Scopus
  9. P. A. Campochiaro, D. M. Brown, C. C. Awh et al., “Sustained benefits from ranibizumab for macular edema following central retinal vein occlusion: twelve-month outcomes of a phase III study,” Ophthalmology, vol. 118, no. 10, pp. 2041–2049, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. Y. Ogura, J. Roider, J. F. Korobelnik et al., “Intravitreal aflibercept for macular edema secondary to central retinal vein occlusion: 18-month results of the phase III GALILEO study,” American Journal of Ophthalmology, vol. 158, no. 5, pp. 1032–1038, 2014. View at Publisher · View at Google Scholar · View at Scopus
  11. P. Fraccaro, M. Nicolo, M. Bonetto et al., “Combining macula clinical signs and patient characteristics for age-related macular degeneration diagnosis: a machine-learning approach,” BMC Ophthalmology, vol. 15, p. 10, 2015. View at Publisher · View at Google Scholar · View at Scopus
  12. W. J. Mayer, A. Wolf, M. Kernt et al., “Twelve-month experience with Ozurdex for the treatment of macular edema associated with retinal vein occlusion,” Eye, vol. 27, pp. 816–822, 2013. View at Publisher · View at Google Scholar · View at Scopus